The most predictive biomarker for 3-month HTN was NGAL combined with TIMP-2×IGFBP-7 at EV preinfusion (AUC [95% CI]: 0.71 [0.62 to 0.80]) (Table 2). This evidence concerns the gene TIMP1 and hypertensive disorder.